NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the pricing of its underwritten public offering of...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Pricing of Public Offering of Common Stock )
Also on site :
- Who Is FSU Shooting Suspect Phoenix Ikner? What We Know
- Man shot and killed by police in Golden Hill this week identified as Enrique Cortez, 37
- Iran responds to Trump: We’ll defend ourselves